Saturday, May 3, 2008 - 05:49 in Mathematics & Economics
The drug developer Bristol-Myers Squibb said it would sell ConvaTec, its wound therapy and surgical care unit, for $4.1 billion to two private equity firms.
- More costly private model of foster care could save $6.3 billion in long termTue, 2 Jun 2009, 13:29:10 EDT
- Methamphetamine use cost the US about $23 billion in 2005, RAND study estimatesWed, 4 Feb 2009, 10:30:01 EST
- Private and public insurance choices could help pay for national health care reformThu, 16 Jul 2009, 0:28:38 EDT
- Firm location determines equity issuanceTue, 24 Jun 2008, 11:29:47 EDT
- Private equity companies purchase nursing homes, but care does not sufferWed, 10 Sep 2008, 9:56:45 EDT